Usefulness of novel potassium adsorbents

Usefulness of novel potassium adsorbents in hyperkalemia patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1021210015

Enrollment

Registered

2021-06-30

Start date

2021-08-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease, hyperkalemia Chronic kidney disease, hyperkalemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Chronic kidney disease patients with hyperkalemia (serum potassium 5.1 mEq / L or higher) or who have already taken potassium adsorbents who have given written consent to this task are eligible.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Compliance rate of SZC	—

Secondary

Measure	Time frame
Characteristics of SZC (easy to drink, taste, texture, portability) Constipation score Changes in defecation status Total number of drugs administered Serum potassium, calcium, magnesium values Presence or absence of electrocardiogram change Blood pressure, pulse rate Presence or absence of other hyperkalemia treatments Patient Satisfaction with SZC	—

Contacts

Public ContactTakeshi Fujita

Hirosaki University

takeshi@hirosaki-u.ac.jp+81-172-39-5057

Outcome results